Products
Fees
Download
Affiliate Program

For Institutions

Corporate Services Developers

Help

About

About Longbridge License & Regulatory Media Coverage Join Us

Home
Discover
News & Info
Trade
PortAI

Discover

News & Info

Quote List Quote List

GF CSI HK Innovative Drugs Industry ETF(QDII)(513120.SH)

Last Updated 00:00:00

longbridge loading

© 2026 Longbridge｜Disclaimer

Event Tracking

Feb17

Innovent Biologics and Eli Lilly Partner to Advance Innovative Drug Development

03:22

Feb16

WuXi AppTec Anticipates Revenue Growth of Approximately 15.84% in 2025

06:39

Jinyao Group's Long-Acting Ropivacaine Injection Approved for Clinical Trials in China

05:35

Sino-Pharm Group's SYH2082 Approved for Clinical Trials

05:34

Macquarie Recommends Buying Shares of Wuxi Biologics and Wuxi Apptec

05:03

Nomura expects 20% revenue growth for Stone Pharmaceutical Group in Q4 2025 and 上调 profit forecast

03:29